TL;DR
This study uses computational methods to investigate how mutations in the SARS-CoV-2 spike protein, particularly in the Omicron variant, affect its interaction with host proteases. They found that Omicron's N679K mutation increases O-linked glycosylation at the S1/S2 cleavage site, potentially hindering cell surface fusion and promoting endocytic entry.
What Problem Does This Paper Address?
The SARS-CoV-2 spike protein is crucial for viral entry into host cells, and its cleavage by host proteases at the S1/S2 site is a key step in this process, facilitating viral-cell fusion and syncytia formation. Different SARS-CoV-2 variants of concern (VOCs) exhibit varying degrees of membrane fusion capacity, with the Omicron variant notably showing reduced cell surface fusion and a preference for endocytic entry. However, the underlying biochemical reasons for these differences, specifically how mutations in the spike protein affect its interaction with proteases like furin and TMPRSS2, remained largely unexplored. This paper aims to bridge this gap by computationally analyzing the structural and biochemical consequences of these mutations on protease recognition and cleavage.
Methods
The researchers employed a suite of bioinformatics and computational techniques:
- Sequence and Structure-Based Bioinformatics: They analyzed the amino acid sequences of spike proteins from various SARS-CoV-2 variants (Wild-type, Alpha, Beta, Gamma, Delta, Omicron, Mu, Lambda) focusing on the S1/S2 and S2' cleavage sites.
- Post-Translational Modification (PTM) Prediction: Tools like NetOGlyc and NetPhos were used to predict potential glycosylation and phosphorylation sites.
- Homology Modeling: They generated 3D models of the spike protein cleavage sites, particularly for variants where experimental structures were unavailable.
- Protein-Protein Docking: Using ensemble docking with ZDOCK and affinity prediction tools (PRODIGY), they simulated the interactions between the spike protein cleavage sites and the host proteases furin and TMPRSS2. This allowed them to assess changes in binding affinity and the structural implications of mutations and PTMs.
Datasets
- SARS-CoV-2 Spike Protein Sequences: Amino acid sequences for the Wild-type and various SARS-CoV-2 variants (Alpha, Beta, Gamma, Delta, Omicron, Mu, Lambda) were obtained from the NCBI Viral Genomes Resource.
- Protease Structures: Crystal structures of furin (PDB: 6hzd) and TMPRSS2 (PDB: 7meq) were used for docking simulations.
- Human Tissue Expression Data: Data on the expression levels of relevant proteases (e.g., GALNT1, PKA, PKC) in respiratory tissues was obtained from the Human Protein Atlas and EMBL-EBI Expression Atlas to contextualize PTM predictions.
Key Insights and Ideas
- Omicron's Glycosylation Advantage: The N679K mutation in Omicron significantly increases the propensity for O-linked glycosylation at the S1/S2 cleavage site. This "glycan shield" could physically block proteases from accessing and cleaving the spike protein.
- Furin vs. TMPRSS2 Affinity: Mutations near the S1/S2 site generally increased predicted affinity to furin but not TMPRSS2. This suggests that furin might play a more significant role in cleaving these mutated spike proteins, potentially influencing entry pathways.
- Phosphorylation Disruption: Mutations at the P681 residue (common in Delta and Alpha) disrupt proline-directed kinase phosphorylation motifs. This disruption might reduce phosphorylation-induced inhibition of protease binding, potentially enhancing fusion capacity for these variants.
- Structural Basis for Entry Differences: The computational modeling provides a structural rationale for why Omicron might favor endocytic entry. The increased glycosylation at S683 could hinder cell surface fusion, forcing the virus into endosomes where other proteases (like cathepsins) can mediate entry.
Key Results
- Increased Furin Affinity: Computational docking showed that mutations at the S1/S2 site in Alpha and Delta variants significantly increased their affinity to furin compared to the Wild-type.
- Omicron's Glycosylation Site: The N679K mutation in Omicron was predicted to lead to O-linked glycosylation at S683, which was found to potentially block protease access to the S1/S2 cleavage site.
- Phosphorylation Site Loss: Mutations at P681 in Alpha and Delta were predicted to remove phosphorylation sites, potentially impacting protease interaction regulation.
- No Significant TMPRSS2 Affinity Change: Unlike furin, mutations at the S1/S2 site did not show a significant increase in predicted affinity to TMPRSS2.
Limitations and Future Work
- In Silico Nature: The study relies heavily on computational predictions. Experimental validation is crucial to confirm these findings regarding PTMs and their impact on protease recognition and viral entry.
- Flexibility of S1/S2 Site: The inherent flexibility of the S1/S2 site poses challenges for precise structural modeling and docking. While ensemble docking was used, it may not fully capture all conformational states.
- PTM Interplay: The study highlights the potential interplay between glycosylation and phosphorylation, but further investigation is needed to fully elucidate these complex interactions and their combined effects on cleavage.
- Other Protease Sites: Mutations outside the S1/S2 and S2' sites, as well as interactions with other proteases (e.g., cathepsins involved in endocytic entry), warrant further investigation.
- Tissue Specificity: The effect of glycosylation on cleavage capacity might vary depending on the expression of specific glycosyltransferases (GALNTs) in different tissues.
The authors emphasize the need for further experimental work to confirm their predictions and to fully understand the structural and functional consequences of these mutations and PTMs on SARS-CoV-2 infectivity and pathogenesis.
Summary updated